Skip to main content
Fig. 5 | EJNMMI Research

Fig. 5

From: Cerenkov luminescence imaging is an effective preclinical tool for assessing colorectal cancer PD-L1 levels in vivo

Fig. 5

Ex vivo biodistribution of 131I-PD-L1-Mab in SW620 (a), LoVo (b), and LS174T (c) tumor-bearing nude mice at 24 h, 48 h, and 120 h after injection. The mean (%IA/g) ± SD at each time point after injection (n = 4 mice at each time point). d Corresponding quantitative data of the tumor (%IA/g)-to-blood (%IA/g) ratio of SW620, LoVo, and LS174T tumor-bearing nude mice

Back to article page